Neuromedin S vs Neuropeptide FF — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Neuromedin S (NMS) is a 36-amino acid amidated neuropeptide discovered in 2005 that shares a C-terminal amino acid sequence with neuromedin U (NMU) and activates the same NMUR1 and NMUR2 receptors. However, NMS has a markedly different expression pattern: while NMU is broadly exp...
Calculate Neuromedin S dose →Neuropeptide FF (NPFF) is an endogenous octapeptide first isolated from bovine brain in 1985 and recognized as a key endogenous anti-opioid system component. NPFF is produced in the hypothalamus, brain stem, and spinal cord and acts on NPFF1 and NPFF2 receptors (GPCRs) to oppose ...
Calculate Neuropeptide FF dose →| Parameter | Neuromedin S | Neuropeptide FF |
|---|---|---|
| Category | Neuropeptide | Neuropeptide |
| Research | Research | Research |
| Half-Life | Short (minutes, estimated) | Short (minutes) |
| Typical Dose | 1-10 nmol (central, animal) | 0.1-10 nmol (central, animal) |
| Frequency | Variable | Variable |
| Route | Intracerebroventricular, Subcutaneous | Intrathecal, Intracerebroventricular (research) |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.